Sofiva GenomicsLtd Balance Sheet Health
Finanzielle Gesundheit Kriterienprüfungen 6/6
Sofiva GenomicsLtd has a total shareholder equity of NT$640.7M and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$775.8M and NT$135.1M respectively. Sofiva GenomicsLtd's EBIT is NT$2.2M making its interest coverage ratio -9.4. It has cash and short-term investments of NT$123.4M.
Wichtige Informationen
0%
Verhältnis von Schulden zu Eigenkapital
NT$0
Verschuldung
| Zinsdeckungsgrad | -9.4x |
| Bargeld | NT$123.42m |
| Eigenkapital | NT$640.72m |
| Gesamtverbindlichkeiten | NT$135.13m |
| Gesamtvermögen | NT$775.84m |
Jüngste Berichte zur Finanzlage
Keine Aktualisierungen
Recent updates
Some Investors May Be Worried About Sofiva GenomicsLtd's (GTSM:6615) Returns On Capital
Apr 14
Estimating The Fair Value Of Sofiva Genomics Co.,Ltd. (GTSM:6615)
Mar 18Sofiva Genomics Co.,Ltd. (GTSM:6615) Investors Should Think About This Before Buying It For Its Dividend
Feb 24Should Weakness in Sofiva Genomics Co.,Ltd.'s (GTSM:6615) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Jan 27Our Take On The Returns On Capital At Sofiva GenomicsLtd (GTSM:6615)
Jan 07
A Look At The Intrinsic Value Of Sofiva Genomics Co.,Ltd. (GTSM:6615)
Dec 15Read This Before Buying Sofiva Genomics Co.,Ltd. (GTSM:6615) For Its Dividend
Nov 24Analyse der Finanzlage
Kurzfristige Verbindlichkeiten: 6615's short term assets (NT$281.0M) exceed its short term liabilities (NT$89.6M).
Langfristige Verbindlichkeiten: 6615's short term assets (NT$281.0M) exceed its long term liabilities (NT$45.6M).
Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital
Verschuldungsgrad: 6615 is debt free.
Schulden abbauen: 6615 had no debt 5 years ago.
Schuldendeckung: 6615 has no debt, therefore it does not need to be covered by operating cash flow.
Zinsdeckung: 6615 has no debt, therefore coverage of interest payments is not a concern.